Speakers

European Congress on Personalised Medicine, Belfast 2017

quill

Personalising Your Health: A Global Imperative!

Note: Additional speakers will be added as the sessions are developed over the next months.

Olivier Arnaud

European Director of Research, Juvenile Diabetes Research Foundation


Ian Banks

EMHF President – Visiting Professor in Men’s Health, University of Ulster UK


Dan Bradley

Head of Molecular Population Genetics Lab, Trinity College Dublin


David Byrne

Former European Commissioner for Health and Consumer Protection and Co-Chair EAPM, Belgium


Gianpiero Cavalleri

Associate Professor in Human Genetics and Deputy Head of the School of Postgraduate Studies, Royal College of Surgeons in Ireland


Stephen Chanock

Chief of DCEG’s Laboratory of Translational Genomics and Director of the NCI Cancer Genomics Research Laboratory


Stuart Elborn

Professor, Queen’s University Belfast


Chris Elliot

Faculty Pro-Vice-Chancellor Medicine, Health and Life Sciences, Queen’s University


John Greally

Professor, Department of Genetics, Albert Einstein College of Medicine


Stanimir Hasardzhiev

Chairperson of the Bulgarian National Patients’ Organization


Eimear Kenny

Assistant Professor of Genetics and Genome Science


Gordon McVie

Senior Consultant at European Institute of Oncology, Milan, Italy Director at Cancer Intelligence Ltd


Walter Ricciardi

President Istituto Superiore di Sanità


Peter Selby

President, ECC


Lilian Sui

Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre


David Waugh

Director of the Centre for Cancer Research and Cell Biology


Gabriella Pravettoni

Director, Applied Research Unit for Cognitive and Psychological Science (IEO)


Chris Fearne

Maltese Minister for Health, Malta


Gunter Danner

Director, German Social Insurance


Francesco De Lorenzo

President, European Cancer Patient Coalition


Francoise Meunier

Vice-President Federation of European Academies of Medicine


Mihaela Militaru

Senior Director – Patient Advocacy & Strategic Partnerships, Merck


David Nutt

President – European Brain Council


Ewa Okoń-Horodyńska

Department of Economics and Innovation Jagiellonian University


Sascha Kress

Senior Client Partner & Strategic Alliance Lead, Life-Science-Pharma, Huawei


Stefania Vallone

President, Lung Cancer Europe (LUCE)


Ludi Schlageter

Vice President Government Affairs and Policy is the Head of the Siemens Healthineers


Mark Lawler

Queen’s University Belfast, United Kingdom


Lydia Mutsch

Minister of Health, Luxembourg


Cristian Silviu Busoi

Member of the European Parliament, Belgium


Gordon McVie

Co-Chair EAPM, Belgium


Carlos Moedas

Commissioner, DG Research, Science and Innovatio, Belgium


Desmond Schatz

School of Medicine University of Florida, USA


Kim Stratton

Head International Commercial, Switzerland


Denis lacombe

European Organisation for Research and Treatment of Cancer, Belgium


Chris Round

Head of EMEA Region for Biopharma Global Commercial Operations, United Kingdom


Lorraine Nolan

Health Products Regulatory Authority, Ireland


Mary Baker

Former President European Brain Council, Belgium


David Waugh

Centre for Cancer Research and Cell Biology, United Kingdom


Ulrich Jäger

University of Vienna, Austria


Richard Barker

University College London, United Kingdom


Gianni D’Errico

Regional Foundation for the Biomedical Research, Italy


Michael Paul Messenger

Leeds Institute of Cancer & Pathology, United Kingdom


Owen Sansom

Cancer Research UK Beatson Institute, United Kingdom


Giovanni Esposito

European Brain Council, Belgium


Michela Tinelli

London School of Economics, United Kingdom


Patrice Boyer

European Psychiatric Association, France


Maartenn I Jzerman

University of Twente, Netherlands


Christine Chomienne

Institut National du Cancer, France


Magda Chlebus

Director Science Policy, Belgium


Vineet Datta

Datar Genetics Limited, India


Luis Mendao

Chair of the the Board of GAT, france


Geoff Hall

Leeds Teaching Hospital NHS Trust, United Kingdom


Bethany Skinkins

University of Leeds, United Kingdom


Paolo Mocarelli

Scientific Director of “don Gnocchi Foundation”, Italy


Sergio Abrignani

Scientific Director Istituto Nazionale di Genetica Molecolare, Italy


Torsten Haferlach

Munich Leukemia Laboratory, Germany


Anita MacDonalds

Birmingham Children’s Hospital, United Kingdom


Anton Hagenbeek

University of Amsterdam, Netherlands


Luca del Gobbo

Regional Ministry University, Italy


Toomas Hendrik Ilves

Former President of Estonia, Estonia


Alastair Kent

Genetic Alliance, United Kingdom


Sue Hill

NHS England, United Kingdom


Sir John Chrisholm

Genomics England, United Kingdom


Mark Caulfield

Genomics England, United Kingdom


Ian Young

Social Services and Public Safety, United Kingdom


Nathalie Moll

Director General, EFPIA, Belgium


Peter Hongaard Anderson

Innovation Fund, Denmark


Atul Gawande

Harvard T.H. Chan School of public health, USA


Richard Baker

University of Oxford/University of London, United Kingdom


Koen Kas

University of Kent, Belgium


Alaxander Eggermont

Institute Gustave Roussy, France


Mike Thompson

Association of British Pharmaceutical Industries, United Kingdom


Toomas Hendrik Ilves

Former President of Estonia, Estonia


Julia Wilson

Welcome Trust Sanger Centre Cambridge UK and Global Aliances for Genomics and Health, United Kingdom


Ewan Birney

Cambridge UK and Chair Global Aliance for Genomics and Health, United Kingdom


Andrew Morris

Director Health Data Research, United Kingdom


Margaret Grayson

Chair Northern Ireland Cancer Research Consumer Forum, United Kingdom


Ain Aaviksoo

Ministry of Social Affair, Estonia


Ernst Hafen

ETH Zurich, Switzerland


Pascal Garel

Hospital and Healthcare Federation (HOPE), Belgium


John Milne

National Institue for Bioprocessing Research and Training (NIBRT), Ireland


Everson Nogoceke

Roche Pharma Research & Early Development, Switzerland


Thomas Keane

EVA and Archive Infrastructure EMBL-EBI


Eva Weinreich-Jensen

HOPE & Senior Advisor, Denmark


Killian O’Driscoll

Director of Projects at NIBRT, Ireland


John F. Cryan

University College Cork, Ireland


Carel Hoyng

Radboud University Nijmegen Medical Centre, Netherlands


Torsten Schwede

University of Basel, Switzerland


Owen Smith

Ireland East Hospital Group, Ireland


Golam Khandaker

University of Cambridge, United Kingdom


Caroline Klaver

Erasmus MC & Radboud UMC, Netherlands


Sarion Bowers

Policy Lead Sanger Institute


Manuel Salto-Tellez

Queens University Belfast, United Kingdom


Imre Lengyel

Queens University Belfast, United Kingdom


Jeff Barrett

Centre for Therapeutic Target Validation, United Kingdom


Stephen McMahon

Chairman and Co-Founder of the Irish Patients Association (IPA), Ireland


Alan Stitt

Queens University Belfast, United Kingdom


Anne-Marie Cairns

Optos Halbeath, United Kingdom


Sir Harpal Kumar

Cancer Research UK, United Kingdom


Mairead O’Driscoll

Health Research Board of Ireland, Ireland


Alberto Bardelli

European Association for Cancer Research, Italy


Sue Hager

Foundation Medicine Inc USA


Gennaro Ciliberto

Instituto Nazionale Tumori “Regina Elena”, Italy


William Gallagher

University College Dublin, Ireland


Shane McKee

Director Northern Ireland Genomics Medicine Centre, United Kingdom


Gianpiero Cavalleri

Royal Collge of Surgeons in Ireland, Ireland


John Field

University of Liverpool, United Kingdom


Andrew Biankin

University of Glasgow, United Kingdom


Michael J. Duffy

University College Dublin, Ireland


Johan den Dunnen

Leiden University Medical Centre, Netherlands


Slave Petrovski

University of Melbourne, Austrailia


Yolande Lievens

European Society for Radiology and Oncology, Belgium


Ali Stunt

Founder of Pancreatic Cancer Action


Ivana Sestak

Queen Mary University of London, United Kingdom


Sally John

Biogen Cambridge, USA


Mary Fitzsimons

Beaumont Hospital, Ireland


Antoni Montserrat

European Commission, Belgium


Lydia Makaroff

ECPC


Fergus Couch

Mayo Clinic, USA


Nadeem Sarwar

Eisai AiM Institute, USA


Norman Delanty

Beaumont Hospital, Ireland


Norman Delanty

Beaumont Hospital, Ireland


Matthias Lohr

Karolinksa Institutet, Sweden


Alric Rüther

Institute for Quality and Efficiency in Health Care, Germany


Anna Middleton

Society and Ethics Research Wellcome Genome Campus, United Kingdom


Mina Gaga

European Respiratory Society, Greece


Alfredo Carrato

Institution Ramon y Cajal University Hospital, Spain


Lucas C. Heukamp

NEO New Oncology AG


Oudkerk Matthijs

Scientific Director Centre for Medical Imaging


Nuria Malats

Spanish National Cancer Research Centre, Spain


Carin Smand

Managing Director, EHA


Paul Biagioni

NICRN


Maurice O’Kane

NICRN


Fionnula Doyle

VP & Global Head Policy of Oncology USA


Carin Smand

Managing Director, EHA


Yann Le Cam

Chief Executive Officer of EURORDIS


Richard Sullivan

King’s College London United Kingdom


Patrick Donnelly

South Eastern Health and Social Care Trust United Kingdom


Anders Olauson

United Nations, USA


Marius Gaenta

Center for Innovation in Medicine, Romania


Vivien Coates

Ulster University, United Kingdom


Maria Luisa Silva

Director of United Nations Development Program, Switzerland


Jana Pelouchova

European Cancer Patient Coalition


Peter Maxwell

Queen’s University, United Kingdom


Ana Rath

Orphanet France


Neil Morgan

Consultant Nephrologist, United Kingdom


Arnie Purushotham

King’s College London United Kingdom


Peter Meeus

Head of Region Europe, Shire


Florin Buicu

Romanian Parliament, Romania


Beata Jagielska

CardioOncology and Palliative Care Poland


Paul Workman

The Institute of Cancer Research, United Kingdom


Ken Mastris

Europa Uomo


Tony Bjourson

Ulster University, United Kingdom


Tunde Peto

Queens University Belfast, United Kingdom


Taavi Rõivas

former Prime Minister of Estonia, Estonia


Vytenis Andriukaitis

European Commissioner for Health and Food Safety, Belgium


Etienne Richter

CIHR Institute of Genetics, Canada


Tom Lillie

Head of European Clinicial Development MSD United Kingdom


Lisa Wilde

Director of Research and External Affairs, Bowel Cancer, United Kingdom


Jonathan Truelove

International, Genomic Health, Switzerland


Tit Albreht

Institute of Public Health, Solvenia


Tom Lillie

Head of European Clinicial Development MSD United Kingdom


Fabian Calvo

Cancer Core Europe, France


Tim Maughan

University of Oxford, United Kingdom


Sheila Walcoff

Goldbug Strategies, USA


Zlatko Trajanoski

Innsbruck Medical University


Sebastian Schmidt

Siemens Healthineers


Denis Claude Roy

Hospital MaisonneuveRosemont Canada


Joshua Hordern

University of Oxford United Kingdom


Stephen Lee

Medicines and Healthcare products Regulatory Agency, United Kingdom


Sergio Quezada

UCL Cancer Institute, United Kingdom


Marc Van Den Bulcke

OD Public Health and Surveillance Scientific Institute of Public Health, Belgium


Marco Marra

Canada’s Michael Smith Genome Sciences Centre, Canada


Sue Spencer

Head of Global Medical Device Services, United Kingdom


Ugur Sahin

co-founder and CEO of BioNTech AG, Germany


Ahti Anttila

Research Director of the Mass Screening Registry of the Finnish Cancer Registry


Alison Hall

Head of Humanities, PHG Foundation United Kingdom


Vincent Houdry

Unit Health Technology and Cosmetics


Ton Schumacher

Netherlands Cancer Institute, Netherlands


Michel Coleman

London School of Hygiene and Tropical Medicine, United Kingdom


Liz Morrell

University of Oxford, United Kingdom


Stephan Scherer

VP Global Head Correlative Science


Dr Claudia Ferrari

The French National Cancer Institute, France


Rob Home

Centre for the Advancement of Sustainable Medical Innovation, United Kingdom


Armin Ritzhaupt

European Medicines Agency


Mary Harney

Former Minister for Health and Deputy Prime Minister, Ireland


Francoise Meunier

Federation of European Academies of Medicine, Belgium


Karen Knudson

Thomas Jefferson University USA


Sue Hager

Foundation Medicine Inc USA


Walter Ricciardi

Instituto Superiore di Sanità, Italy


J Stuart Elborn

London and Queen’s University Belfast, United Kingdom


Lorraine Martin

Queen’s University Belfast, United Kingdom


Eimear Kenny

Icahn School of Medicine at Mount Sinai, USA


Joe McHugh

Minister of State for the Diaspora and International Development


Walter Kolch

University College Dublin Ireland


Nina Renshaw

European Public Health Alliance


Holger Moch

University Hospital Zurich, Switzerland


John Greally

Albert Einstein College of Medicine, USA


Dan Longley

Queens University Belfast, United Kingdom


Derick Mitchell

IPPOSI, Ireland


Mark Higgins

Vertex, USA


Dan Bradley

Trinity College Dublin, Ireland


Jochen Prehn

Royal College of Surgeons in Ireland, Ireland


Frank Kee

Queen’s University Belfast, United Kingdom


Kristine Sørensen

Founder, Global Health Literacy Academy, Netherlands


Kaisa Immonen

European Patient Forum


Michelle Francis Naylor

United Kingdom


Geoffrey Henning

EuropaColon, Belgium


Tõnu Esko

University of Tartu, Estonia


Janet Allen

Cystic Fibrosis Trust, United Kingdom


Karen Benn

Europa Donna


Tito Fojo

Columbia University, USA


Virginia Acha

Association of the British Pharmaceutical Industry, United Kingdom


Pierre Meulien

Innovation Medicines Initiative


Kaja Kallas

Member of the European Parliament


Kathy Olivero

International Brain Tumor Alliance


Simon Hollingsworth

AstraZeneca, United Kingdom


Philip Beer

Cure Forward Corp, United Kingdom


Brian O’Connor

European Connected Health Alliance


Christopher Elliot

Queen’s University Belfast, United Kingdom


Kenneth Fleming

Centre for Global Health NCI, USA


Richard Kennedy

Queen’s University Belfast, United Kingdom


Jim McLaughlin OBE

University of Ulster Northern, Ireland


Moira Dean

Queen’s University Belfast, United Kingdom


Darren Hodgson

AstraZeneca, United Kingdom


Dr Mike Scott

Medicines Optimisation Innovation Centre, Northern Ireland


Alice Stanton

Royal College of Surgeons in Ireland, Ireland


Matt Squires

Executive Director Oncology Precision Medicine Novartis, Switzerland


George Crooks OBE

Digital Health & Care Institute, Scotland


Sue Horton

University of Waterloo, Canada


AKrishna Prasad

MHRA


Robert Hemmings

MHRA


Louis Garrison

International Society For Pharmacoeconomics and Outcomes Research, USA


Juergen Scheuenpflug

Global Head Clinical Biomarkers & Companion Diagnostics


Urve Palo

Minister of Entrepreneurship and Information Technology, Estonia


Iñaki Gutiérrez-Ibarluzea

Vice President en Health Technology Assessment international (HTAi), Spain


Maura O’Donovan

Health Products Regulatory Authority, Ireland


Peter Kapitein

Inspire2Live, Netherlands


Hendrik Van Poppel

European Association of Urology


Olivier Arnaud

Juvenile Diabetes Research Foundation


David Barton

National Centre for Medicial Genetics Crumlin /em>


Mario Pazzagli

University of Florence, Italy


Lou Garrison

University of Washington, USA


Nicolas Mottet

Université Jean Monnet, France


Colin Dayan

Cardiff University, United Kingdom


Clare Hague

Celgene, Ireland


Rodolfo Montironi

EAU Section of Uropathology, Italy


Andrew Winterbottom

Treasurer of ECPC and Director of Fight Bladder Cancer, United Kingdom


Carole Longson

National Institute for Health Care & Excellence, United Kingdom


Thorsten Bach

European Association of Urology


Stephen Halloran

University of Surrey, United Kingdom


Thomas Danne

M.D., Diabetes Centre for Children and Adolescents, Hannover, Germany


Martin Crockard

Randox Laboratories Ltd, United Kingdom


Hans-Georg Eichier

European Medicines Agency, United Kingdom


Simon Patton

European Molecular Genetics Quality Network


Lars Pedersen

Aarhus University, Denmark


Gillian Docherty

The Data Lab


Jevgeni Ossinovski

Minister of Health, Estonia


Alojz Peterle

Member of the European Parliament, Belgium


Stephen Friend

Leader Health Team, Apple Inc.


Stanimir Hasurdjiev

Secretary-General of the Patient Access Partnership


IN CLOSE COLLABORATION WITH OUR PARTNERS

Get Updates by Email

 

REGISTER NOW